JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Clinical trial NCT06108050 · RECRUITING
Trial details
- NCT number
- NCT06108050
- Sponsor
- Jazz Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-07
- Primary completion
- 2027-11-30
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.